Literature DB >> 18508795

No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia.

Raffaella Origa, Susanna Barella, Giovanni Maria Argiolas, Patrizio Bina, Annalisa Agus, Renzo Galanello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18508795     DOI： 10.3324/haematol.12484

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia.

Authors:  Paolo Ricchi; Massimiliano Ammirabile; Anna Spasiano; Silvia Costantini; Tiziana Di Matola; Alessia Pepe; Patrizia Cinque; Leonilde Pagano; Maddalena Casale; Aldo Filosa; Luciano Prossomariti
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

Review 3.  Liver iron content determination by magnetic resonance imaging.

Authors:  Konstantinos Tziomalos; Vassilios Perifanis
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 4.  Management of non-transfusion-dependent thalassemia: a practical guide.

Authors:  Ali T Taher; Maria Domenica Cappellini
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

5.  Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.

Authors:  Khaled M Musallam; Maria Domenica Cappellini; John C Wood; Irene Motta; Giovanna Graziadei; Hani Tamim; Ali T Taher
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

Review 6.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

Review 7.  β-Thalassemia.

Authors:  Raffaella Origa
Journal:  Genet Med       Date:  2016-11-03       Impact factor: 8.822

8.  Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.

Authors:  Athanasios Aessopos; Vasilios Berdoukas
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-18       Impact factor: 2.576

Review 9.  Treating iron overload in patients with non-transfusion-dependent thalassemia.

Authors:  Ali T Taher; Vip Viprakasit; Khaled M Musallam; M Domenica Cappellini
Journal:  Am J Hematol       Date:  2013-03-08       Impact factor: 10.047

10.  Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis.

Authors:  Ekatherina Stoyanova; Guy Cloutier; Hady Felfly; Wafaa Lemsaddek; Nicolas Ah-Son; Marie Trudel
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.